Idowu O, Hayes-Jordan A
University of California Davis-East Bay, Oakland, CA 94609, USA.
J Pediatr Surg. 1998 Aug;33(8):1251-3. doi: 10.1016/s0022-3468(98)90161-0.
BACKGROUND/PURPOSE: The risk of septicemia in postsplenectomy pediatric patients is approximately 2%. This risk is twice as great for children less than 4 years of age. In the first year of life this risk can be 30% or higher. Partial splenectomy is an alternative in patients with hemoglobinopathies. The authors attempt to assess the outcome of pediatric patients less than 4 years of age undergoing partial splenectomy using the Argon beam.
In a tertiary care, university affiliated, dedicated children's hospital seven patients underwent partial splenectomy (PS) by the same surgeon from May 1993 to September 1995. The PS performed for trauma was excluded. Included were patients with hemoglobinopathies. Therefore, six patients were evaluated. Follow-up was from 6 months to 2 years. Pre- and postoperative blood transfusions, length of operation, estimated blood loss, length of hospital stay, postoperative complications, perfusion, and function of remnant spleen were evaluated.
Indications for splenectomy included sequestration crisis and hypersplenism. Percent splenectomy ranged from 65% to 75%. Average hospital stay was 6.3 days. Postoperative splenic function, measured by Pitt count and radionuclide spleen scan, was normal. Postoperatively there were no systemic infections, overwhelming postsplenectomy sepsis (OPSS), torsion of the splenic remnant, left upper quadrant fluid collections, or subphrenic abscesses. There were no deaths.
Partial splenectomy is a safe and effective procedure in children less than 4 years of age with hemoglobinopathies. The procedure as described yields minimal blood loss and retains immune competence. Partial splenectomy greatly reduces, and in some cases eliminates, the need for blood transfusions. PS should be considered the procedure of choice in children less than 4 years of age with sickle cell anemia or beta-thalassemia who require splenectomy.
背景/目的:脾切除术后小儿患者发生败血症的风险约为2%。4岁以下儿童的这一风险是其两倍。在生命的第一年,这一风险可达30%或更高。对于患有血红蛋白病的患者,部分脾切除术是一种替代治疗方法。作者试图评估4岁以下接受氩束部分脾切除术的小儿患者的治疗结果。
在一家三级医疗、大学附属的儿童医院,1993年5月至1995年9月间,同一位外科医生为7例患者实施了部分脾切除术(PS)。因创伤而进行的PS被排除在外。纳入的是患有血红蛋白病的患者。因此,对6例患者进行了评估。随访时间为6个月至2年。评估了术前和术后输血情况、手术时间、估计失血量、住院时间、术后并发症、残余脾脏的灌注和功能。
脾切除的指征包括脾功能亢进危象和脾功能亢进。脾切除百分比在65%至75%之间。平均住院时间为6.3天。通过皮特计数和放射性核素脾扫描测量的术后脾功能正常。术后无全身感染、暴发性脾切除后败血症(OPSS)、残余脾脏扭转、左上象限积液或膈下脓肿。无死亡病例。
部分脾切除术对于4岁以下患有血红蛋白病的儿童是一种安全有效的手术。所述手术失血量极少,并保留免疫功能。部分脾切除术大大减少,在某些情况下消除了输血的必要性。对于患有镰状细胞贫血或β地中海贫血且需要脾切除的4岁以下儿童,PS应被视为首选手术方法。